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Abstract
 
The evolutionarily conserved, secreted protein Twisted gastrulation (Tsg) modulates morpho-
genetic effects of decapentaplegic (dpp) and its orthologs, the bone morphogenetic proteins 2
and 4 (BMP2/4), in early 
 
Drosophila
 
 and vertebrate embryos. We have uncovered a role for
Tsg at a much later stage of mammalian development, during T cell differentiation in the thy-
mus. BMP4 is expressed by thymic stroma and inhibits the proliferation of CD4
 
 
 
CD8
 
 
 
 dou-
ble-negative (DN) thymocytes and their differentiation to the CD4
 
 
 
CD8
 
 
 
 double-positive
(DP) stage in vitro. 
 
Tsg
 
 is expressed by thymocytes and up-regulated after T cell receptor sig-
naling at two developmental checkpoints, the transition from the DN to the DP and from the
DP to the CD4
 
 
 
 or CD8
 
 
 
 single-positive stage. Tsg can synergize with the BMP inhibitor
chordin to block the BMP4-mediated inhibition of thymocyte proliferation and differentiation.
These data suggest that the developmentally regulated expression of 
 
Tsg
 
 may allow thymocytes
to temporarily withdraw from inhibitory BMP signals.
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Introduction
 
Thymocyte differentiation is controlled by signals via the
pre-TCR and the TCR (for reviews, see references 1–3).
Progression from the CD4
 
 
 
CD8
 
 
 
 double-negative (DN)
 
*
 
to the CD4
 
 
 
CD8
 
 
 
 double-positive (DP) stage in cells des-
tined for the TCR 
 
  
 
 lineage is driven by pre-TCR sig-
 
naling and requires TCR
 
 
 
 chain rearrangement, expression,
and pairing with the pre-TCR 
 
 
 
 chain. The acquisition of
CD4 and CD8 is accompanied by a burst of proliferation,
the cessation of further V to DJ rearrangement at the TCR
 
 
 
 locus and proceeds through a transitional stage where (in
the mouse strains used in this study) CD8 is expressed be-
fore CD4 (1). Recombination-deficient thymocytes are
 
blocked at the CD4
 
 
 
CD8
 
 
 
CD25
 
 
 
CD44
 
 
 
 stage of develop-
ment but antibodies to the CD3
 
 
 
 signaling chain can
mimic pre-TCR signaling and trigger progression to the
DP stage (2). Further development from the DP to the
CD4
 
 
 
 or CD8
 
 
 
 single-positive (SP) stage of development
requires rearrangement and pairing of TCR
 
 
 
 with TCR
 
 
 
and the engagement of the resulting heterodimer with suit-
able peptide/MHC ligands on thymic stromal cells (3).
The control of cellular differentiation by antigen recep-
tor rearrangement, expression, and engagement is unique
to lymphocytes and (in evolutionary terms) a recent addi-
tion to older systems comprising soluble and cell-associated
factors that control the survival, growth, and differentiation
of cells and tissues in all multicellular organisms. For exam-
ple, thymocyte survival and differentiation are promoted by
cytokines including IL-7 (4), c-Kit ligand (5), IL-1, and
TNF (6), and signaling through Notch (7) participates in T
cell lineage commitment (8). Comparatively little is known
about the role of patterning molecules or morphogens in
lymphocyte development (9–12).
In a screen for genes that are regulated in a developmen-
tal stage-specific manner in thymocytes (13) we have iden-
tified 
 
Twisted gastrulation
 
 (
 
Tsg
 
; reference 14). Recent studies
have revealed that the Tsg protein interacts with 
 
Drosophila
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decapentaplegic (dpp), the vertebrate dpp orthologs bone
morphogenetic protein (BMP)2/4, and also the extracellu-
lar dpp/BMP inhibitors short gastrulation (sog)/chordin
(15–20). In addition, Tsg can alter the proteolytic process-
ing of sog/chordin by extracellular metalloproteases (16,
20). As a result, Tsg affects the binding of dpp/BMP2/4 to
their cellular receptors and downstream signaling events
mediated by the phosphorylation, nuclear translocation,
and transcriptional activity of Smad proteins (for a review,
see reference 21) positively (15, 20) or negatively (16–20).
BMPs belong to a family of secreted signaling molecules
the founding member of which, TGF
 
 
 
, is essential for im-
mune homeostasis (11, 22). In addition to a well-estab-
lished role in embryonic patterning and development (23),
BMP4 has been linked to hematopoesis: it specifies ventral
mesoderm and blood cell formation in the 
 
Xenopus
 
 embryo
(24), cooperates with VEGF to enhance hematopoetic cell
generation from ES cells (25), is expressed in the human fe-
tal AGM region (26), and regulates primitive human he-
matopoetic cell proliferation (27). There is evidence that
components of the BMP signaling pathway are expressed in
the thymus, including BMP4 itself (9), the extracellular
BMP inhibitor chordin (28), the BMP receptor compo-
nents activin-like kinase (ALK)-3 and -6 (BMPR1A and
-B; reference 29), and Smad proteins (30, 31), the down-
stream mediators of BMP signaling. However, a role for
BMP signals in thymocyte development has not been de-
scribed. Furthermore, our understanding of 
 
Tsg
 
 is currently
limited to early embryonic development (15–20, 32). We
have investigated the effects of BMP4 and its modulation
by Tsg during the transition from the CD4
 
 
 
CD8
 
 
 
 DN to
the CD4
 
 
 
CD8
 
 
 
 DP stage of thymocyte development.
 
Materials and Methods
 
Mouse Strains, Cell Sorting, Cell and Organ Culture.
 
Thymi
were derived from wild-type (BALB/c or C57BL/6), recombina-
tion activating gene (Rag)1
 
o/o
 
 (33), or A
 
 
 
o/o
 
 
 
 
 
2m
 
o/o
 
 (34, 35; re-
ferred to as MHC
 
o/o
 
 in this manuscript). Where indicated, 3–4-
wk-old Rag-1
 
o/o
 
 mice were injected with 50 
 
 
 
g of the CD3
 
 
 
mAb 2C11 (BD PharMingen). Thymocyte organ cultures and
suspension cultures of mechanically dissociated or trypsinized fetal
thymi were set up as hanging drops in inverted Terasaki plates
(Nunc) in serum-free AIM-V lymphocyte medium (GIBCO
BRL) supplemented with 2 
 
 
 
 10
 
 
 
5
 
 M 2-ME, where indicated in
the presence of recombinant BMP2, -4, and -7, chordin, neutral-
izing anti-BMP4 or BMPR-IA/Fc (all from R&D Systems),
TGF
 
 
 
1 (Sigma-Aldrich), or the CD3
 
 
 
 antibody 2C11 (BD
PharMingen). Recombinant mouse Tsg was produced in X63
myeloma cells transfected with full-length mTsg cDNA (14)
tagged with a COOH-terminal HA epitope and inserted into the
BCMGS neo vector (36). Supernatant was concentrated, mTsg-
HA captured with anti-HA–conjugated agarose beads (Sigma-
Aldrich) and eluted by incubation of the washed beads with 100
 
 
 
g/ml HA peptide (Sigma-Aldrich). Western analysis of the ma-
terial with an anti-HA antibody (Sigma-Aldrich) showed a single
band at 
 
 
 
25 kD. Tsg concentration was estimated by gel staining
since the HA peptide used for elution interfered with measure-
ment of protein concentration. Supernatant from X63 cells trans-
fected with empty BCMGS neo vector treated in the same way
 
served as a control for mTsg-HA. All Tsg effects were confirmed
using commercial mTsg (R&D Systems) which became available
during the course of this study.
For some experiments thymocytes were stained with biotiny-
lated antibodies to CD4 or CD8 and depleted with streptavidin-
coated paramagnetic beads (Dynal). Thymic stromal cells were
prepared by trypsinization of deoxyguanosine-treated fetal thymi
and centrifugation over 55% Percoll (Amersham Pharmacia Bio-
tech). Wild-type thymi were cultured for 18 to 72 h, thymus cell
suspensions and thymocytes for 18 h, and Rag1
 
o/o
 
 thymi for 48–
72 h in the presence of the 2C11 mAb at 1 
 
 
 
g/ml. For pheno-
typic analysis on a FACSCalibur™ (Becton Dickinson) cells were
counted and stained with CD4-PE or Cy-5 and CD8-FITC or
-Cy5 (Caltag Laboratories), fixed for 10 min at room temperature
in 0.2% paraformaldehyde, permeabilized with 0.2% Tween-20
for 15 min at 37
 
 
 
C, and incubated with 7-amino actinomycin D
(7AAD). For sorting of DN and CD8 transitional cells on a
FACS Vantage™ (Becton Dickinson), thymocytes were stained
with CD4-Tricolor, CD8-PE (Caltag Laboratories), and heat sta-
ble antigen (HSA)-FITC.
 
Immunohistochemistry and RNA In Situ Hybridization on Frozen
Sections.
 
Thymi from 3–4-wk-old C57BL/6 mice were snap
frozen, 6-
 
 
 
m sections were prepared. For immunohistochemis-
try, sections were fixed in acetone and stained using polyclonal
goat anti-BMP2/4 (R&D Systems) followed by horseradish per-
oxidase–conjugated rabbit anti–goat Ig antibody (Dako) and liq-
uid DAB substrate-chromogen solution (Dako) according to the
manufacturer’s instructions. Slides were counterstained with
Mayer’s Hematoxylin (Sigma-Aldrich) and mounted in Kaiser’s
solution (14). Sense and antisense riboprobes were synthesized
from a cloned PCR fragment spanning exon 4 of mTsg (14) in
the presence of 11-dUTP digoxigenin (Roche) with T3 or T7
RNA polymerase. After hybridization, high-stringency washing,
and RNase A digestion, the sections were incubated with alkaline
phosphatase–conjugated anti-digoxigenin (Roche). BCIP/NBT
(Roche) was used as substrate for detection. The sections were
counterstained with nuclear fast red (Vector Laboratories),
mounted in Mowiol solution (Calbiochem), and photographed.
 
Molecular Cloning and Analysis.
 
Expression studies were per-
formed as reported previously (14, 37). For Northern blots, 1–5
 
 
 
g total RNA were separated on 1% agarose gels containing for-
mamide. The RNA was transferred to HybondN
 
 
 
 Nylon
membranes and hybridized in 1.5
 
 
 
 SSPE, 10% PEG 8000, 7%
SDS at 68
 
 
 
C overnight. After washing in decreasing SSC con-
centrations and a final stringency wash in 0.1
 
 
 
 SSC, 0.5% SDS
at 60
 
 
 
C the membranes were exposed to BioMax-MS film (East-
man Kodak Co.).
For reverse transcription (RT)-PCR experiments, 0.3–1 
 
 
 
g
total RNA were reverse transcribed with AMV reverse tran-
scriptase (Promega) and amplified with the following primers at
annealing temperatures of 60
 
 
 
C to 63
 
 
 
C: BMP2 no. 465 TAC-
CGCAGGCACTCAGG, no. 466 CATTCCACCCCACAT-
CACT; BMP4 no. 467 CGAGGCGACACTTCTACAG, no.
468 TGGGGGCTTCATAACCT; chordin: no. 473 CAAGC-
CTCAGCGGAAGAA, no. 474 CAAGCCCAGCCAATA-
GAACT; GAPDH: no. 251 TCTTCTTGTGCAGTGCC, no.
252 ACTCCACGACATACTCAGC. PCR products were ana-
lyzed on 2% agarose gels and the identity of the bands was con-
firmed by blotting and hybridizing with specific probes.
 
Western Blotting.
 
Phospho-Smad
 
 (
 
pSmad)-2–specific antibod-
ies were used to assess the phosphorylation status of Smad-2.
Thymocyte lysates were separated (2 
 
 
 
 10
 
6
 
 cell equivalents per
lane) on 10% SDS polyacrylamide gels and blotted onto PVDF 
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membranes (NEN Life Science Products). Blots were blocked
(1% nonfat milk in PBS, 0.1% Tween 20 for p-Smad-2; 5% non-
fat milk in PBS) and probed with rabbit anti-pSmad2 (Upstate
Biotechnology 06–829) followed by alkaline phosphatase–conju-
gated anti–rabbit IgG and enhanced chemoluminescence detec-
tion (Western Star; Tropix) on MR-1 film (Eastman Kodak Co.).
Blots were stripped and reprobed for total Smad-2 and subse-
quently for lamin B to control for equal loading and transfer effi-
ciency (not shown).
 
Results
 
Tsg Up-regulation After TCR Signaling at Control Points in
Thymocyte Development.
 
We undertook a screen to find
novel genes involved in T cell development. MHC-naive
CD4
 
 
 
CD8
 
 
 
 DP thymocytes (isolated from MHC
 
o/o
 
 mice)
were cocultured with thymic stromal cells derived from
MHC-expressing (wild-type) or, as a control, from MHC
 
o/o
 
thymi (37). This system allowed a comparison of gene ex-
pression profiles between MHC-exposed and MHC-naive
thymocytes by differential display PCR (13). The charac-
terization of a band consistently up-regulated upon TCR
signaling resulted in the cloning of the mouse homologue
of 
 
Tsg
 
 (14). Northern blotting confirmed increased 
 
Tsg
 
 ex-
pression by MHC-naive DP thymocytes between 6 and 24 h
after treatment with antibodies to the TCR alone or in
combination with anti-CD28 (Fig. 1 a). To investigate 
 
Tsg
 
expression at the pre-TCR–driven transition from the
CD4
 
 
 
CD8
 
 
 
 DN to the CD4
 
 
 
CD8
 
 
 
 DP stage we injected
Rag1
 
o/o
 
 mice with antibodies to CD3
 
 
 
. Thymocyte devel-
opment in Rag1
 
o/o
 
 mice is blocked at the CD44
 
 
 
CD25
 
 
 
DN stage of differentiation and can be rescued by CD3
 
 
 
treatment in vivo which triggers a synchronous wave of
differentiation from the CD44
 
 
 
CD25
 
 
 
 DN to the DP
stage (2). This was accompanied by a rise in 
 
Tsg
 
 expression
that occurred around 48 h after anti-CD3 injection (Fig. 1
b), at a time when thymocytes showed reduced CD25 ex-
pression and increased proliferation but were still DN (ref-
 
erence 2, and data not shown). We conclude that 
 
Tsg
 
 is
differentially expressed after TCR signaling at two devel-
opmental checkpoints, the transition from the CD4
 
 
 
CD8
 
 
 
DN to the CD4
 
 
 
CD8
 
 
 
 DP and from the DP to the CD4
 
 
 
or CD8
 
 
 
 SP stage.
The recognized role of Tsg as a modulator of BMP sig-
naling (15–20) prompted us to reevaluate the expression of
components of the BMP signaling pathway in the thymus
(see Introduction). RT-PCR showed the expression of
BMP2, BMP4, BMP7, and chordin in total thymus tissue
(Fig. 2 a). Analysis of separated thymocytes and thymic
stroma established thymic stromal cells as the source of
BMP2/4 and chordin. BMP7 was expressed by both thy-
mocytes and stromal cells (Fig. 2 a). Semiquantitative RT-
PCR analysis confirmed that thymocytes expressed BMP7
at levels similar to total thymus whereas the levels of BMP4
and chordin expression in thymocytes were 20- to 100-fold
lower in thymocytes than total thymus (data not shown).
The distribution of BMP2/4 protein in the thymus was vi-
sualized by immunohistochemistry on frozen sections (Fig.
2, b–e). We noted marked regional differences with stain-
ing predominantly of subcapsular (sc) and medullary (med)
regions. Within these areas the signal appeared ‘patchy’
rather than uniform (Fig. 2, c and e). In situ hybridization
showed 
 
Tsg
 
 expressing cells distributed throughout the cor-
tex and the medulla (Fig. 2, f–h).
 
BMP4 Can Interfere with Cell Cycle Activity and Develop-
mental Progression of DN Thymocytes.
 
To assess the func-
tional effects of BMPs we established thymic organ cul-
tures at embryonic day 15.5 (E15.5), a time in ontogeny
when all thymocytes are DN, and analyzed the cell cycle
distribution as well as the phenotype of thymocytes that
developed in these cultures. Addition of BMP4 at 100 ng/
ml (
 
 6 nM) reduced the percentage of thymocytes in S
and G2/M phase of the cell cycle by 42   9% (Fig. 3, a
and b). This inhibition was largely abrogated by a neutral-
izing antibody to BMP4 (Fig. 3 a). Conversely, treatment
of thymic organ cultures with recombinant chordin 2  g/
ml ( 20 nM) increased the percentage of thymocytes in S
and G2/M by 59   30% (Fig. 3 a). As chordin is an extra-
cellular inhibitor specifically of BMPs but not of TGF  or
activin (21), the increased proliferation of thymocytes in
intact thymic lobes treated with chordin suggests that thy-
mocyte cell cycle activity is subject to BMP-mediated in-
hibition in situ.
In addition to proliferation, BMP4 treatment of E15.5
thymic organ cultures interfered with the developmental
progression from the CD4 CD8  DN to the CD4 CD8 
DP stage (Fig. 3 b) and reduced the generation of DP cells
on average by 52   21% (Fig. 3 c). In control experi-
ments, the survival of sorted E17 DP thymocytes was un-
affected by overnight culture in BMP4 (100 ng/ml), indi-
cating that BMP4 was not simply toxic to DP thymocytes
(data not shown).
The reduced generation of DP thymocytes in the pres-
ence of BMP4 could be explained either by a delay in
TCR  chain rearrangement or by a reduced response to
pre-TCR signaling. To address this issue we assayed BMP4
Figure 1. TCR-regulated Tsg expression by thymocytes. (a) Increased
Tsg mRNA expression by MHC-naive DP thymocytes in response to an-
tibodies to the TCR, with or without CD28 engagement. (b) Increased
Tsg mRNA expression by DN thymocytes 48 h after injection of Rag-1o/o
mice with anti-CD3 . In additional experiments, Tsg upregulation occurred
between 24 and 72 h and persisted until 120 h after injection.166 Twisted gastrulation in Thymocyte Development
effects on the differentiation of Rag1-deficient thymocytes
in response to CD3  antibody (1  g/ml) as a surrogate sig-
nal which does not require TCR  chain rearrangement.
BMP4 treatment reduced the development of DP thy-
mocytes in Rag1o/o organ cultures treated with CD3  anti-
bodies by 46   22% (Fig. 3 c).
To ask whether BMP4 inhibition of the DN to DP tran-
sition required an intact thymic microenvironment, E15.5
thymi were disrupted by trypsinization to yield suspensions
containing all thymic cell types including thymic stroma.
BMP4 blocked the DN to DP transition by 52   17%.
Similarly, BMP4 blocked the DN to DP transition in me-
Figure 2. Expression and distribution of intrathymic BMPs and chordin. (a) Total thymus or isolated stromal cells and thymocytes were subjected to
RT-PCR analysis to establish the sources of BMP2, BMP4, BMP7, and chordin in the thymus. GAPDH served as a positive control. H2O lanes con-
tained no cDNA. (b–e) Immunoperoxidase staining of normal 3–4-wk-old mouse (C57BL/6) thymus with goat anti-BMP/24 (c and e) or control goat
antibody (b and d). BMP2/4 staining (brown) is seen mainly within supcapsular (sc) and medullary (med, outlined in c) regions (original magnification:
 200, b and c) and ‘patchy’ within positive areas (original magnification:  400, d and e). (f–h) In situ hybridization of normal 3–4-wk-old mouse
(C57BL/6) thymus with Tsg sense (f) and antisense (g and h) probes. Tsg expressing cells are distributed throughout the cortex and the medulla. Original
magnification:  100 (f and g),  200 (h).167 Graf et al.
chanically prepared E15.5 thymocyte suspensions by 72  
8% (Fig. 3 c).
The ability of BMP4 to inhibit thymocyte differentia-
tion in suspension cultures allowed us to define the
BMP4 sensitivity of thymocytes at different developmen-
tal stages and, in addition, to ask whether BMP4 acts di-
rectly on thymocytes or via intermediate cell types.
When E17 thymocyte suspensions were depleted of
CD8  thymocytes to yield pure DN cells, BMP4 inhib-
ited the generation of DP cells by 80   13%. In contrast,
when E17 thymocyte suspensions were depleted only of
CD4  thymocytes, leaving behind DN as well as CD8
transitional cells, BMP4 was less effective at inhibiting
the generation of DP cells (36   10%). Hence, DN thy-
mocytes were more sensitive to BMP4 than CD8 transi-
tional cells (Fig. 3 c).
To determine whether BMP4 affects thymocyte de-
velopment directly or indirectly, DN thymocytes were
highly purified by two rounds of cell sorting for
HSAhighCD4 CD8  thymocytes, yielding populations that
contained 0.3% or less of cell types other than thymocytes.
Sorted thymocytes differentiated efficiently to the DP stage
and BMP4 inhibited this by 72% and 73% in two indepen-
dent experiments. The developmental progression of highly
purified CD8 transitional cells was blocked by BMP4 to a
lesser degree, by 26 and 29% in two independent experi-
ments (Fig. 3 c). Hence BMP4 acts directly on DN thy-
mocytes to inhibit their progression to the DP stage.
Figure 3. BMP4 inhibits the cell cycle
activity and the developmental progression
of DN thymocytes to the DP stage. (a)
E15.5 thymic lobes were cultured in hang-
ing drops for 24–36 h with BMP4 (100 ng/
ml, 6 nM approximately), BMP4 (100
ng/ml) plus neutralizing anti-BMP4 (10
 g/ml) or chordin (2  g/ml, 20 nM ap-
proximately). Thymocytes were stained for
CD4 and CD8, fixed, permeabilized, and
DNA content was visualized by 7AAD. The
fraction of cells with a DNA content  G1
is shown relative to control cultures (16  
7%  G1). (b) Reduced cell cycle activity
and impaired developmental progression in
BMP4-treated E15.5 thymic organ cultures
(36 h, methods as in a). (c) BMP4 (100 ng/
ml) inhibited the DN to DP transition in
E15.5 thymic organ cultures by 52   21%
(from 50   10% DP to 25   13% at 36 h,
top row) and in Rag1o/o thymic organ cul-
tures treated for 72 h with anti-CD3  (1
 g/ml) by 46   22% (from 57   4% DP to
32   12%, row two). BMP4 reduced the
generation of DP cells in proteolytically
dissociated E15.5 thymus suspensions by
52   17% (from 59   13% DP to 28   9%,
third row), in mechanically prepared E15.5
thymocyte suspensions by 72   8% (from
44   19% DP to 13   6%, row four), in
DN cells prepared by CD8 depletion of E17
thymocytes by 80   13% (from 33   16%
to 8   8%, row five), in DN/CD8 transi-
tional thymocytes prepared by CD4 deple-
tion of E17 thymocytes by 36   10% (from
66   23% DP to 44   20%, row six), in
highly purified DN by 72% (from 39% DP
to 11%) and 73% (from 40% DP to 10%) in
two experiments (row seven), and in highly
purified CD8 transitional thymocytes by
26% (from 91% DP to 67%) and 29%, (from
83% DP to 59%) in two experiments (row
eight, all suspension culture experiments
read out at 18 h). Recombinant BMPR-
IA/Fc (bottom row, 1–3  g/ml) increased
the generation of DP cells in E15.5 thymic
lobes cultured for 18 h by 67   28% (from
23 to 38%, n   4). (d) E15.5 thymus sus-
pensions were cultured with 300 ng/ml of
BMP4 or BMP7 and analyzed as in Fig. 3, b
and c. BMP4 reduced the generation of DP
cells by 73   7% (from 50   27% DP to 14  
9%) but BMP7 did not (1   5%).168 Twisted gastrulation in Thymocyte Development
We exploited the observation that BMP2 and 4 (and to a
lesser extent BMP7) but not TGF  or activin can bind
BMPR-IA with high affinity in the absence of type II re-
ceptor subunits (38, 39) to address whether the DN to DP
transition is affected by endogenous BMPs. Soluble BMP
receptor-IA subunit (BMPR-IA) was added to intact E15.5
thymic lobes in organ culture. In the presence of BMPR-
IA, the percentage of DP thymocytes (analyzed 18 h later
instead of 24–36 h in the organ culture experiments de-
scribed above) was elevated by 67   28% relative to con-
trol thymi (Fig. 3 c) and the number of DP cells per thymic
lobe increased by 94   57% (not shown).
Exogenous BMP2 blocked the DN to DP transition to
the same extent as BMP4 (not shown). In contrast, BMP7
did not inhibit the DN to DP transition (Fig. 3 d), even at
very high concentrations (1,000 ng/ml, not shown).
Smad-2 Phosphorylation in Response to TGF  but Not
BMP4 in Thymocytes. Like BMP4, TGF  blocks thy-
mocyte cell cycle activity and developmental progression
(10, 40). To address the question whether thymocytes can
distinguish BMP4 from TGF  signals we analyzed the
phosphorylation status of Smad-2, a downstream mediator
of TGF  signals (21) in thymocytes cultured with TGF 1
at 1 ng/ml or a range of BMP4 concentrations from 0.1 to
1,000 ng/ml. Phosphorylated Smad-2 was readily detected
in response to TGF  but not to BMP4 by Western blotting
with pSmad-2–specific antibodies (Fig. 4). Hence, BMP4
signaling does not appear to utilize the canonical TGF  sig-
naling pathway in thymocytes. An analysis of Smad-1 phos-
phorylation in response to exogenous BMP4 remained in-
conclusive as pSmad-1 appeared to be present in freshly
isolated thymocytes (not shown, and see Discussion).
Tsg Synergizes with the BMP Inhibitor Chordin to Block
BMP4 Effects on Thymocyte Differentiation. As described in
Fig. 3 c, BMP4 inhibited the developmental progression
from the DN to DP stage in Rag1o/o organ cultures treated
with CD3 . In the presence of BMP4 (100 ng/ml) the
BMP inhibitor chordin restored the generation of DP cells
only partially, even when added in threefold molar excess
(2  g/ml). We used this system to assess the functional ef-
fects of Tsg. On its own (not shown) or in combination
with BMP4 (100 ng/ml), Tsg (1  g/ml,  40 nM) had lit-
tle effect. In combination with chordin, however, TSG
was able to reverse the inhibitory effects of BMP4 on the
generation of DP thymocytes in anti-CD3 –treated Rag1o/o
organ cultures (Fig. 5 a, top panel). Rescue of DP differen-
tiation from BMP4-mediated inhibition by chordin and
Tsg was also seen in trypsinized suspension cultures of
E15.5 thymi. Again, chordin antagonized BMP4 only par-
tially, Tsg on its own was without effect, but the combina-
tion of chordin and Tsg rescued DP thymocyte develop-
ment effectively (Fig. 5 a, bottom panel). A representative
experiment is shown in Fig. 5 b.
The ratio between chordin and Tsg was found critical
for BMP antagonism read out as secondary axis formation
in zebrafish (19). We therefore performed experiments in
which the concentrations of BMP4 (100 ng/ml) and chor-
din (2  g/ml) were kept constant and Tsg was titrated over
a wide range of concentrations, from 0.03 to 3,000 ng/ml
(Fig. 5 b). Tsg addition resulted in a dose-dependent inhi-
bition of the BMP4 block on the DN to DP transition. We
conclude that Tsg can synergize with chordin to antagonize
BMP4-mediated inhibition of the DN to DP transition. In
this system there was no indication that Tsg had BMP-ago-
nistic effects at any ratio of chordin and Tsg tested.
Discussion
The key observation of our study is that immature thy-
mocytes express Tsg, an extracellular modifier of BMP2/4
activity, in a developmentally regulated fashion: pre-TCR
and TCR signaling results in increased Tsg expression at
two developmental checkpoints, the DN to DP and the
DP to SP transition (Fig. 1). Tsg has recently been shown
to interact with extracellular components of the BMP sig-
naling pathway (15–20), prompting us to investigate effects
of BMP4 on thymocyte development. We found that DN
thymocytes are highly susceptible to BMP4, which acts di-
rectly and without relay by another cell type to reduce DN
thymocyte proliferation and progression to the DP stage in
vitro (Fig. 3 c). The thymocyte response to BMP4 appears
not to utilize the canonical TGF  signaling cascade as indi-
cated by the phosphorylation of Smad-2 in response to
TGF  but not to BMP4 (Fig. 4).
The addition of specific BMP inhibitors to intact thymic
lobes results in elevated rates of thymocyte proliferation
(Fig. 3 a) and accelerated pre-TCR dependent differentia-
tion to the DP stage (Fig. 3 c), indicating that a BMP-
imposed ‘brake’ may be active in situ. Conversely, exogenous
BMP4 interferes with DN proliferation progression to the
DP stage (Fig. 3, a–d), suggesting that endogenous BMP2/4
levels are subsaturating, or, alternatively, that not all thy-
mocytes are exposed to equal BMP2/4 levels in situ. The
latter possibility is consistent with our analysis of thymic
sections where (in contrast to the uniform expression of
BMP in early embryos; for a review, see reference 23) we
found marked regional differences: BMP2/4 was seen pre-
dominantly in subcapsular and medullary areas and showed
an uneven, ‘patchy’ distribution within these areas (Fig. 2,
c and e). By analogy to the Drosophila ovary where the
Figure 4. TGF  but not BMP4 induce Smad-2 phosphorylation in
thymocytes. Thymocytes from E17 (or postnatal, not shown) wild-type
(C57BL/6) mice were cultured with TGF 1 (1 ng/ml) or the indicated
concentrations of BMP4 for 45 min and cell lysates assayed for pSmad-2
by Western blot.169 Graf et al.
BMP2/4 ortholog dpp serves to retain germ cell precursors
in a concentration-dependent fashion (41) one might spec-
ulate that BMP2/4-rich areas represent specialized mi-
croenvironments geared toward the retention of precursor
cells. In contrast to BMP2/4, the expression of BMP7
(which together with BMP5 and -6 forms the 60A sub-
group of BMPs distinct from BMP2/4; reference 23) is not
restricted to thymic stroma and BMP7 is expressed abun-
dantly in thymocytes (Fig. 2 a). Interestingly, exogenous
BMP7 did not inhibit the DN to DP transition (Fig. 3 d).
Differences in the response to BMP2/4 and 7 have previ-
ously been seen in developing neurons (42, 43). Both
BMP2/4 and BMP7 signaling involve Smad-1 (21, 23) and
it is unclear how developing neurons (42, 43) or thy-
mocytes (this study) discriminate between these BMPs.
BMP7 may contribute to pSmad-1 seen in freshly isolated
thymocytes (data not shown). In addition to BMP2/4 (this
paper), TGF 1 and the morphogen sonic hedgehog (Shh)
can block the pre-TCR–dependent transition from the
DN to the DP stage in vitro (9, 40). The relationship be-
tween BMP, Shh, and Wnt signals in the thymus remains
to be defined. In certain developmental contexts Shh acts
upstream of dpp/BMP2/4 (27, 41, 44–47). Conversely,
Wnt and its downstream effectors (which can promote thy-
mocyte differentiation; references 11 and 12) have been
shown to block BMP4 expression in Xenopus embryos (48).
Reportedly, Tsg can either facilitate or antagonize dpp/
BMP2/4 activity (15–20), perhaps because the release of
dpp/BMP2/4 from the extracellular inhibitors sog/chordin
is alternatively blocked (16) or facilitated (20) by the pro-
teolytic processing of sog/chordin by metalloproteases of
the tolloid/BMP1 family. The relative abundance of Tsg
and chordin can be critical for whether Tsg acts as an ago-
nist or an antagonist of dpp/BMP2/4 (17). In our own ex-
periments Tsg synergized with chordin to antagonize
BMP4 in a simple, dose-dependent manner (Fig. 5). If
BMP2/4 originating from thymic stroma can block the ex-
pansion and differentiation of DN thymocytes in vivo, the
developmentally regulated expression of Tsg could serve to
temporarily antagonize inhibitory BMP effects following
successful TCR  rearrangement and pre-TCR expression
Figure 5. Tsg synergizes with chordin to block the effects of ex-
ogenous BMP4 on thymocyte developmental progression. (a) Top
panel; Rag1o/o organ cultures were treated with the anti-CD3  anti-
body 2C11 for 3 d (1  g/ml) with the addition of BMP4 (100 ng/
ml), chordin (2  g/ml), and/or Tsg (1  g/ml). Thymocytes were
analyzed as in Fig. 3. Note the restoration of DP thymocyte develop-
ment by the combination of chordin and Tsg. Bottom panel; suspension cultures of wild-type E15.5 thymi cultured overnight with the same additions as
in top panel. (b) Suspension cultures of wild-type E15.5 thymi were cultured overnight and analyzed as in a. (c) E15.5 thymus suspensions were treated
with BMP4 (100 ng/ml, left diagonal pattern), chordin (2  g/ml, right diagonal pattern), or BMP4 plus chordin (cross-hatched) with or without Tsg
(0.03 to 3,000 ng/ml) and analyzed as in Fig. 3. The percentage of DP thymocytes generated after 24 h is given (mean   SD, n   4).
Figure 6. How BMP4, chordin, and Tsg may affect the pre-TCR–
dependent DN to DP transition (see text for details).170 Twisted gastrulation in Thymocyte Development
(Fig. 6). We speculate that the balance between BMP2/4,
chordin, and Tsg may ensure developmental progression
while maintaining a sufficient pool of immature precursors.
Although these ideas are consistent with our data on the
developmental regulation of Tsg expression in vivo and our
experiments in vitro, we emphasize that BMPs may have
additional functions in the thymus. For example, a role at
the DP stage is implied by differential Tsg expression in re-
sponse to TCR engagement at the DP stage (Fig. 1) and
the recently reported failure of thymocyte differentiate to
the SP stage in the absence of Schnurri2, a putative down-
stream target of BMP signaling (49). Moreover, BMP4 and
dpp act as morphogens in vertebrate and Drosophila em-
bryos where they form activity gradients to specify distinct
cell fates along the dorsal/ventral axis (23, 50–53). It will
therefore be of interest to find out whether local BMP2/4
concentration specifies alternative fates such as    versus
   at the DN to DP transition or CD4 versus CD8 at the
DP to SP transition.
Our finding of developmentally regulated Tsg expression
in the thymus extends the concept that cells within a mor-
phogenetic field not only read and respond to the local
morphogen concentration but can be instrumental in shap-
ing the morphogen gradient (52, 53). It suggests that cells
can temporarily withdraw from signaling molecules affect-
ing their differentiation via the increased expression of a se-
creted modifier at specific developmental control points.
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